Pancreatic ductal adenocarcinoma cells that display relatively high expression of ErbB3 (S2-013, CAPAN-1, HPAF-II and AsPC-1), overcome erlotinib-induced growth inhibition when exposed to NRG-1β (Figure 4B). Here, ERBB3 is linked to pancreatic ductal adenocarcinoma.